Certain habits and food choices can affect how well you tolerate the medication and achieve your goals
Is promotional financing available on Mayo Clinic Diet program purchases
Because these treatments often lead to substantial changes in eating patterns and body weight, it can sometimes be difficult to determine whether the medication, weight loss itself, or another factor is responsible
"FLOW is the first ever renal outcomes trial with a GLP-1 receptor agonist, and demonstrated a statistically significant reduction in kidney disease progression, cardiovascular death, and all-cause mortality risk with semaglutide 1 mg," Michael Radin, executive medical director for diabetes at Novo Nordisk, said in a statement sent to Fox News Digital
Well explore possible reasons why GLP-1 medications might influence mood, review what the research says so far, identify who may be most at risk, andmost importantlyoffer strategies to help protect your emotional well-being while using semaglutide